abstract |
The present invention relates to CCR3 receptor ligands of general formula (I) or (IA), preferably antagonists therein, and salts and isomers thereof, pharmaceutical compositions containing them, general formulas (I) and ( IA) and the use of salts and isomers thereof and the preparation of the compounds of general formulas (I) and (IA) and their salts and isomers. |